Consistently, high TME Gal-9 levels correlated with increased frequencies of tumor-infiltrating lymphocytes (TILs) and PD-L1 expression on cancer cells in early stage triple-negative breast cancer (TNBC) indicative of anti-tumorigenic Gal-9 effects [149]. This evidence concerns the gene LGALS9 and triple-negative breast carcinoma.